Pyrimidines as PLK inhibitors

Details Pyrimidines as PLK inhibitors Pyrimidines as PLK inhibitors

2007-07-10

2007-07-10

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S323000, C544S324000

Reexamination Certificate

active

11132091

ABSTRACT:
The present invention comprises compounds of general formula (1)whereinA, X, Y, Z, Ra, Rb, Rc, R1, R2and R3are defined as in claim1, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, and the use thereof for preparing a pharmaceutical composition with the above-mentioned properties.

REFERENCES:
patent: 6593326 (2003-07-01), Bradbury et al.
patent: 2003/0114472 (2003-06-01), De Corte et al.
patent: 2004/0039005 (2004-02-01), De Corte et al.
patent: 2005/0090493 (2005-04-01), Breault et al.
patent: WO 2000/12485 (2000-03-01), None
patent: WO 2000/27825 (2000-05-01), None
patent: WO 2004/080980 (2004-09-01), None
patent: WO 2004080980 (2004-09-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010. 1996.
Ahmed FASEB Journal 18, 5-7, 2004.
Turner et al., Current Pharmaceutical Design. 2, 209-224, 1996.
Sugar et al., Diagn. Microbiol. Infect. Dis. 21: 129-133, 1995.
Snyder et al., J. Med. Liban 48(4): 208-214, 2000.

Affiliated with

Also associated with

Rating

Pyrimidines as PLK inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidines as PLK inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidines as PLK inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3732884